HRP20110654T1 - Dimeri derivata artemizinina, njihovo dobivanje i upotreba u terapiji - Google Patents
Dimeri derivata artemizinina, njihovo dobivanje i upotreba u terapiji Download PDFInfo
- Publication number
- HRP20110654T1 HRP20110654T1 HR20110654T HRP20110654T HRP20110654T1 HR P20110654 T1 HRP20110654 T1 HR P20110654T1 HR 20110654 T HR20110654 T HR 20110654T HR P20110654 T HRP20110654 T HR P20110654T HR P20110654 T1 HRP20110654 T1 HR P20110654T1
- Authority
- HR
- Croatia
- Prior art keywords
- epoxy
- decahydro
- trimethyl
- trifluoromethyl
- image
- Prior art date
Links
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical class C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 title 1
- 239000000539 dimer Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000003839 salts Chemical class 0.000 claims abstract 6
- 239000002253 acid Substances 0.000 claims abstract 4
- 239000012453 solvate Substances 0.000 claims abstract 4
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims abstract 2
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 claims abstract 2
- 230000001093 anti-cancer Effects 0.000 claims abstract 2
- 150000002118 epoxides Chemical class 0.000 claims abstract 2
- 239000000047 product Substances 0.000 claims 17
- -1 2,1-ethanediyloxy Chemical group 0.000 claims 7
- 239000004593 Epoxy Substances 0.000 claims 6
- MFJCPDOGFAYSTF-UHFFFAOYSA-N 1H-isochromene Chemical compound C1=CC=C2COC=CC2=C1 MFJCPDOGFAYSTF-UHFFFAOYSA-N 0.000 claims 3
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 claims 1
- 125000004450 alkenylene group Chemical group 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 239000013067 intermediate product Substances 0.000 claims 1
- 229940126601 medicinal product Drugs 0.000 claims 1
- 125000005699 methyleneoxy group Chemical group [H]C([H])([*:1])O[*:2] 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/04—Seven-membered rings not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
- C07D321/02—Seven-membered rings
- C07D321/04—Seven-membered rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
- C07D323/04—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0603209A FR2899586B1 (fr) | 2006-04-11 | 2006-04-11 | Dimeres de derives d'artemisinine, leur preparation et leur application en therapeutique |
PCT/FR2007/000585 WO2007116135A1 (fr) | 2006-04-11 | 2007-04-06 | Dimeres de derives d'artemisinine, leur préparation et leur application en thérapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20110654T1 true HRP20110654T1 (hr) | 2011-10-31 |
Family
ID=37429238
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20110654T HRP20110654T1 (hr) | 2006-04-11 | 2011-09-13 | Dimeri derivata artemizinina, njihovo dobivanje i upotreba u terapiji |
Country Status (40)
Country | Link |
---|---|
US (1) | US8314142B2 (es) |
EP (1) | EP2007769B1 (es) |
JP (1) | JP5265518B2 (es) |
KR (1) | KR101357523B1 (es) |
CN (1) | CN101421276B (es) |
AR (1) | AR060400A1 (es) |
AT (1) | ATE512970T1 (es) |
AU (1) | AU2007235813B2 (es) |
BR (1) | BRPI0710152A2 (es) |
CA (1) | CA2641138C (es) |
CR (1) | CR10247A (es) |
CY (1) | CY1111833T1 (es) |
DK (1) | DK2007769T3 (es) |
EA (1) | EA015607B1 (es) |
EC (1) | ECSP088792A (es) |
ES (1) | ES2367715T3 (es) |
FR (1) | FR2899586B1 (es) |
GT (1) | GT200800206A (es) |
HK (1) | HK1131779A1 (es) |
HN (1) | HN2008001521A (es) |
HR (1) | HRP20110654T1 (es) |
IL (1) | IL194655A0 (es) |
JO (1) | JO2721B1 (es) |
MA (1) | MA30410B1 (es) |
ME (1) | ME00094B (es) |
MX (1) | MX2008012732A (es) |
MY (1) | MY154970A (es) |
NO (1) | NO20084352L (es) |
NZ (1) | NZ571342A (es) |
PE (1) | PE20080055A1 (es) |
PL (1) | PL2007769T3 (es) |
PT (1) | PT2007769E (es) |
RS (1) | RS51952B (es) |
SI (1) | SI2007769T1 (es) |
TN (1) | TNSN08321A1 (es) |
TW (1) | TWI423979B (es) |
UA (1) | UA94744C2 (es) |
UY (1) | UY30276A1 (es) |
WO (1) | WO2007116135A1 (es) |
ZA (1) | ZA200808025B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2925495B1 (fr) * | 2007-12-21 | 2010-09-10 | Pf Medicament | Derives dimeriques d'artemisinine et application en therapie anticancereuse |
FR2934593B1 (fr) * | 2008-07-29 | 2010-09-10 | Pf Medicament | Derives dimeriques d'artemisinine et application en therapie anticancereuse |
US8883765B2 (en) * | 2009-12-08 | 2014-11-11 | The John Hopkins University | Anti-cytomegalovirus activity of artemisinin-derived dimers |
US8815942B2 (en) | 2010-10-20 | 2014-08-26 | The Royal Institution For The Advancement Of Learning/Mcgill University | Combination therapy and uses thereof for treatment and prevention of parasitic infection and disease |
CN102010422B (zh) * | 2010-11-23 | 2014-11-26 | 沈阳药科大学 | 含有胍基的青蒿素类衍生物及其应用 |
CN102614168A (zh) * | 2011-01-31 | 2012-08-01 | 上海交通大学医学院附属瑞金医院 | 一种青蒿素衍生物及其药用盐的应用 |
WO2012111025A2 (en) * | 2011-02-14 | 2012-08-23 | Council Of Scientific & Industrial Research | 1,2,3-triazole containing artemisinin compounds and process for preparation thereof |
WO2014023081A1 (zh) * | 2012-08-07 | 2014-02-13 | 中国科学院上海生命科学研究院 | 青嵩素衍生物及其制法和应用 |
CN106928274B (zh) * | 2017-02-28 | 2019-09-10 | 东南大学 | 一种双氢青蒿素二倍体衍生物、其药物组合物及应用 |
CN110240605B (zh) * | 2018-03-08 | 2021-12-31 | 中国科学院上海药物研究所 | 青蒿素二聚物的制备方法 |
CN109467565B (zh) * | 2018-08-16 | 2020-07-10 | 云白药征武科技(上海)有限公司 | 双氢青蒿素三聚体及其制备方法和应用 |
US20220175937A1 (en) * | 2019-02-26 | 2022-06-09 | Mahmoud A. Elsohly | Selected artemisinin dimers for the treatment of lashmaniasis |
CN117285548A (zh) * | 2022-06-16 | 2023-12-26 | 云南苏理生物医药科技有限公司 | 一种含硫类青蒿素二聚体、其制备方法和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1084333C (zh) * | 1998-06-17 | 2002-05-08 | 中国科学院上海药物研究所 | 新的青蒿素化合物,其制备方法以及含有它们的药物组合物 |
FR2831538B1 (fr) * | 2001-10-26 | 2004-01-16 | Centre Nat Rech Scient | Nouveaux derives de l'artemisinine, et leurs utilisations dans le traitement du paludisme |
US6790863B2 (en) * | 2002-10-15 | 2004-09-14 | University Of Mississippi | Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents |
CA2570961C (en) * | 2004-06-21 | 2015-09-01 | University Of Mississippi | Anticancer and antiprotozoal dihydroartemisinene and dihydroartemisitene dimers with desirable chemical functionalities |
CN101125142A (zh) | 2007-07-24 | 2008-02-20 | 北京中医药大学东直门医院 | 青蒿素在制备抗肿瘤多药耐药药物中的应用 |
-
2006
- 2006-04-11 FR FR0603209A patent/FR2899586B1/fr not_active Expired - Fee Related
-
2007
- 2007-04-06 CN CN200780013054XA patent/CN101421276B/zh not_active Expired - Fee Related
- 2007-04-06 SI SI200730713T patent/SI2007769T1/sl unknown
- 2007-04-06 DK DK07731259.3T patent/DK2007769T3/da active
- 2007-04-06 ZA ZA200808025A patent/ZA200808025B/xx unknown
- 2007-04-06 EP EP07731259A patent/EP2007769B1/fr active Active
- 2007-04-06 KR KR1020087024812A patent/KR101357523B1/ko not_active IP Right Cessation
- 2007-04-06 PT PT07731259T patent/PT2007769E/pt unknown
- 2007-04-06 ME MEP-2008-123A patent/ME00094B/me unknown
- 2007-04-06 UA UAA200813044A patent/UA94744C2/ru unknown
- 2007-04-06 JP JP2009504774A patent/JP5265518B2/ja not_active Expired - Fee Related
- 2007-04-06 MX MX2008012732A patent/MX2008012732A/es active IP Right Grant
- 2007-04-06 RS RS20110399A patent/RS51952B/en unknown
- 2007-04-06 PL PL07731259T patent/PL2007769T3/pl unknown
- 2007-04-06 BR BRPI0710152-0A patent/BRPI0710152A2/pt not_active IP Right Cessation
- 2007-04-06 EA EA200870421A patent/EA015607B1/ru not_active IP Right Cessation
- 2007-04-06 NZ NZ571342A patent/NZ571342A/en not_active IP Right Cessation
- 2007-04-06 CA CA2641138A patent/CA2641138C/fr not_active Expired - Fee Related
- 2007-04-06 AT AT07731259T patent/ATE512970T1/de active
- 2007-04-06 AU AU2007235813A patent/AU2007235813B2/en not_active Ceased
- 2007-04-06 ES ES07731259T patent/ES2367715T3/es active Active
- 2007-04-06 MY MYPI20084058A patent/MY154970A/en unknown
- 2007-04-06 WO PCT/FR2007/000585 patent/WO2007116135A1/fr active Application Filing
- 2007-04-09 PE PE2007000422A patent/PE20080055A1/es not_active Application Discontinuation
- 2007-04-10 AR ARP070101497A patent/AR060400A1/es not_active Application Discontinuation
- 2007-04-10 TW TW096112535A patent/TWI423979B/zh not_active IP Right Cessation
- 2007-04-11 UY UY30276A patent/UY30276A1/es not_active Application Discontinuation
- 2007-04-11 JO JO2007131A patent/JO2721B1/en active
-
2008
- 2008-08-07 TN TNP2008000321A patent/TNSN08321A1/en unknown
- 2008-08-26 CR CR10247A patent/CR10247A/es unknown
- 2008-10-02 US US12/244,225 patent/US8314142B2/en not_active Expired - Fee Related
- 2008-10-03 HN HN2008001521A patent/HN2008001521A/es unknown
- 2008-10-06 EC EC2008008792A patent/ECSP088792A/es unknown
- 2008-10-07 IL IL194655A patent/IL194655A0/en unknown
- 2008-10-08 GT GT200800206A patent/GT200800206A/es unknown
- 2008-10-16 NO NO20084352A patent/NO20084352L/no not_active Application Discontinuation
- 2008-11-10 MA MA31376A patent/MA30410B1/fr unknown
-
2009
- 2009-10-21 HK HK09109745.0A patent/HK1131779A1/xx not_active IP Right Cessation
-
2011
- 2011-09-13 HR HR20110654T patent/HRP20110654T1/hr unknown
- 2011-09-15 CY CY20111100886T patent/CY1111833T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20110654T1 (hr) | Dimeri derivata artemizinina, njihovo dobivanje i upotreba u terapiji | |
RU2403258C2 (ru) | Тиазолилдигидроиндазолы | |
DK2026775T3 (en) | USE OF SYK tyrosine kinase inhibitors for treating cell proliferative DISORDERS | |
EP2292593A3 (en) | Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors | |
US7964738B2 (en) | Pharmaceutical compositions and methods of use of lipophilic, silicon-substituted, cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs and derivatives | |
JP5441928B2 (ja) | 一酸化窒素供与化合物 | |
JP2009504763A5 (es) | ||
JP2010505873A5 (ja) | 化合物、会合複合体、及び会合複合体を形成する方法 | |
JP2010077141A5 (es) | ||
EA005817B1 (ru) | Производные гексагидро-7-1h-азепин-2-илгексановой (или гексеновой) кислоты в качестве ингибиторов индуцибельной синтазы оксида азота | |
JP2002543202A5 (es) | ||
SE0302760D0 (sv) | New compounds | |
JP2004501189A5 (es) | ||
MX2007004740A (es) | Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica. | |
MX2009012041A (es) | Derivados de 1,3-dihidroimidazol-2-tiona como inhibidores de dopamina-beta-hidroxilasa. | |
JP2006504738A5 (es) | ||
RU2020119562A (ru) | Хиназолиноновое соединение и его применение | |
RU2013112807A (ru) | Композиция для доставки активных агентов в желудок | |
RU2009128970A (ru) | Производные изосорбидмононитрата для лечения кишечных заболеваний | |
WO2003049676A3 (en) | Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the teatment of cancer | |
JP2019503356A5 (es) | ||
RU2506072C2 (ru) | Фармацевтическая композиция, содержащая 11-дезокси-простагландиновое соединение, и способ стабилизации этого соединения | |
WO2015106283A1 (en) | Antifungal compounds | |
EA200100597A2 (ru) | Новые 1,1- и 1,2-дизамещенные циклопропановые соединения, способ их получения и содержащие их фармацевтические композиции | |
WO2010004579A3 (en) | Orally active curcuminoid compounds |